Similarly, the interaction between PD‐1 receptor and its ligand PD‐L1 and PD‐L2, that are expressed by both TILs and tumor cells such as CTLA‐4, can reduce proliferation, and survival of T‐cells.13, 14. The gene discussed is CTLA4; the disease is neoplasm.